Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Scientific Officer

Chief Operating Officer

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule that is in Phase I clinical trial for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule, which is in Phase I clinical trial for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; and WTX-712, an IL-21 INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the t...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-01-06	Premium	bought	Premium	Premium	Premium	-
2022-01-12	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2021-12-30	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2021-12-15	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2021-06-16	Premium	bought	Premium	Premium	Premium	-
2021-06-15	Premium	bought	Premium	Premium	Premium	-
2021-06-14	Premium	bought	Premium	Premium	Premium	-
2021-05-04	Premium	bought	Premium	Premium	Premium	-
2021-05-04	Premium	acquired	Premium	Premium	Premium	-
2021-05-04	Premium	acquired	Premium	Premium	Premium	-
2021-05-04	Premium	bought	Premium	Premium	Premium	-
2021-05-04	Premium	acquired	Premium	Premium	Premium	-
2021-05-04	Premium	bought	Premium	Premium	Premium	-
2021-05-04	Premium	acquired	Premium	Premium	Premium	-
2021-05-04	Premium	bought	Premium	Premium	Premium	-
2021-05-04	Premium	acquired	Premium	Premium	Premium	-
2021-05-04	Premium	bought	Premium	Premium	Premium	-
2021-05-04	Premium	acquired	Premium	Premium	Premium	-
2021-05-04	Premium	acquired	Premium	Premium	Premium	-
2021-05-04	Premium	bought	Premium	Premium	Premium	-
2021-05-04	Premium	bought	Premium	Premium	Premium	-
2021-05-04	Premium	acquired	Premium	Premium	Premium	-
2021-05-04	Premium	bought	Premium	Premium	Premium	-
2021-05-04	Premium	acquired	Premium	Premium	Premium	-
2021-05-04	Premium	bought	Premium	Premium	Premium	-

HOWL - Werewolf Therapeutics, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for HOWL